1. Use of dupilumab in bullous pemphigoid: where are we now?;Russo;J Clin Med,2022
2. Efficacy and safety of dupilumab in moderate-to-severe bullous pemphigoid;Zhang;Front Immunol,2021
3. Bullous pemphigoid: the role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy;Zhang;Front Immunol,2023
4. Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient;Zhou;JAAD Case Rep,2022
5. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology;Santi;An Bras Dermatol,2019